Yixi Bio Invites You to the 7th Future Healthcare 100 Summit 2023
Over the past decade, the global healthcare industry has undergone significant restructuring, a transformation accelerated by the COVID-19 pandemic since 2020. Having withstood the compounded challenges of global upheaval and the century-defining pandemic from 2020 to 2022, 2023 marked the first year for implementing the strategic deployments outlined at the 20th National Congress of the Communist Party of China, as well as a critical year for advancing the 14th Five-Year Plan. Only by accumulating strength, demonstrating the resilience to “remain steadfast despite countless trials,” and embodying the spirit to “press forward in the face of greater difficulties,” can innovators in the healthcare sector reinforce their confidence through decisive action, thereby delivering a high-quality response to the era’s demands for the advancement of healthcare.
The 7th Future Healthcare Top 100 Conference, themed “Beyond East and West,” was hosted by VCBeat VB100 and Eggshell Research Institute, in strategic partnership with Shanghai Zhangjiang Group. Integrating cutting-edge academic research insights, comprehensive industry perspectives, and keen capital market trends, the conference took place from May 5–7, 2023, at the Zhangjiang Science Hall in Shanghai. It brought together industry peers to explore the innovative future of the broader health sector and embark on a new journey in healthcare innovation.
Having convened for six editions, the conference has become China’s largest and most information-rich ecosystem summit fostering integration between industry and capital within the healthcare innovation sector. Centered on “connecting global wisdom, sharing cutting-edge technologies, inspiring the technological future, and focusing on venture capital interaction,” it sets the direction for innovation and investment in China’s healthcare field. The 2023 7th Future Healthcare 100 Conference will feature three flagship summits, over 20 thematic forums across specialized sectors, the release of the Future Healthcare 100 series rankings and awards, more than ten series reports, and seven concurrent networking events. Distinguished attendees—including government agencies, academicians and scientists, clinical and research experts, Fortune 500 and listed companies, top-tier investment institutions and securities firms, and innovative healthcare enterprises—will gather for this intellectual convening to provide industry insights and usher in a new future.
“Only ask for courage, only ask for blossoming, ask not of west or east” makes a powerful arrival!
Synthetic biology has become the most prominent annual hotspot attracting attention from both industry and capital sectors. At the Synthetic Biology Industry Innovation and Development Forum of the Future Healthcare Top 100 Conference, the founder of Yixi BioDr. Zhenyun Liuwill attend and deliver the presentation “Development of Industrial Production Processes for Biosynthetic HMOs》Keynote Speech: Delivering in-depth insights on technological innovation and practical applications to empower integrated industrial innovation, while sharing Yixi Bio’s experience and lessons learned in the industrial-scale manufacturing process and commercialization journey of HMOs.
Conference Schedule:
May 5–7, 2023
Conference Registration:
